Laure Kairawicz is a distinguished Principal Investigator at Thermo Fisher Scientific, where she plays a pivotal role in advancing the development of innovative gene therapy vectors, including AAV, lentivirus, and adenovirus systems. With her extensive expertise in analytical methodologies and project management, Laure leads cross-functional...
Laure Kairawicz is a distinguished Principal Investigator at Thermo Fisher Scientific, where she plays a pivotal role in advancing the development of innovative gene therapy vectors, including AAV, lentivirus, and adenovirus systems. With her extensive expertise in analytical methodologies and project management, Laure leads cross-functional teams to integrate cutting-edge technologies that enhance product development and streamline processes. Her proficiency in Agile frameworks allows her to adapt quickly to project demands, ensuring that deliverables align with both financial objectives and timelines.
A certified Project Management Professional (PMP), Laure is adept at navigating complex project landscapes, employing her analytical thinking skills to identify potential risks and implement effective risk management strategies. Her leadership extends beyond project execution; she is also the lead inventor for several patent initiatives focused on Analytical Ultracentrifugation (AUC) data analysis, showcasing her commitment to innovation in the field.
In addition to her technical acumen, Laure is passionate about fostering a culture of agility and continuous improvement within her teams. She provides Agile coaching and training, empowering her colleagues to embrace iterative methodologies that enhance productivity and collaboration. Her diverse skill set, which includes expertise in chromatography and assay development, positions her as a key contributor to Thermo Fisher Scientific's mission of delivering exceptional value to clients and advancing the frontiers of scientific research. Through her leadership and vision, Laure Kairawicz continues to drive transformative projects that shape the future of biopharmaceutical development.
